CMA also degrades proteins associated with Alzheimer’s disease and frontotemporal dementia, such as MAPT (Tau) (Wang et al., 2009), TARDBP (Huang et al., 2014), and APP (Park et al., 2016). Here, MAPT is linked to Alzheimer disease.